
The START Center for Cancer Research has dosed the first US participant in Moderna’s phase 1 clinical trial evaluating mRNA-4106, …

Moderna has expanded its partnership with Benchling, a cloud-based research platform, to support its broader research organisation. Previously used by …

Global researcher of mRNA medicine, Moderna, has been granted authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) to …

Moderna has announced that the US Food and Drug Administration (FDA) has shared that it will not complete its review …

Merck (known as MSD outside of the US and Canada) and Moderna have announced the initiation of the phase 3 …

Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …

Biotechnology company Moderna has announced that it has completed submission of a regulatory application to the US Food and Drug …

Canada has become the first country in the world to grant full approval to the Moderna vaccine, alongside confirmation for …

Data presented by Pfizer and Moderna ahead of the FDA’s vaccine advisory committee meeting on Friday suggest that protection from …

Moderna has initiated the rolling submission process with the FDA for a Biologics License Application (BLA) for the licensure of …

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …

Moderna’s mRNA booster jabs for people already vaccinated against COVID-19 have shown positive initial data in a Phase II study …

Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …

Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …

The first Moderna COVID-19 vaccine in the UK has today been administered, beginning the rollout of the country’s third vaccine …